(Boursier.com) — Spie Building Solutions and Spie Industrie, French subsidiaries of Spieare participating in the development of a new production unit at the Evreux factory GlaxoSmithKline (GSK).
After having successfully accomplished two achievements since 2018 for this biopharmaceutical company, Spie was asked to set up this new production line dedicated to inhalers in new generation and low carbon aerosol form, with a clear and ambitious objective of reducing of the carbon footprint.
Created in 1968, GSK’s Evreux site, which has nearly 1,100 employees, specializes in the production of inhaled medicines intended to treat asthma and chronic obstructive pulmonary disease (COPD). With the aim of decarbonization, GSK is redeveloping its current product which aims to replace the propellant gas contained in aerosol inhalers with a more environmentally friendly alternative. This will reduce the carbon footprint of this product by 90%. The pharmaceutical factory called on the expertise and experience of Spie Building Solutions and Spie Industrie to participate in the creation of this low-carbon production line, within its Normandy site.
The work, which began in July 2023, aims to be finalized in the first half of 2024.
©2024 Boursier.com